Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06428617Recruiting

Fundus Ablation Registry (Gastric Fundus Mucosal Ablation for Weight Loss)

Role: lead

NCT06420700Recruiting

Ablation Registry (Combined Gastric Mucosal Ablation With Endoscopic Sleeve Gastroplasty for Weight Loss)

Role: lead

NCT05578703Not ApplicableActive Not Recruiting

ABLATE WEIGHT (Ablation Plus ESG for Weight Loss)

Role: lead

NCT05870943Not ApplicableActive Not Recruiting

Hybrid Argon Plasma Coagulation and Endoscopic Sleeve Gastroplasty Validation Study

Role: lead

NCT05992103Not ApplicableUnknown

ABLATE WEIGHT 2 (Single-Stage Fundic Ablation Plus ESG for Weight Loss)

Role: lead

All 5 trials loaded